|
|
||||||||
Istituto di Fisiologia Umana I, Università di Milano, 20133, Milano, Italy
| |
ABSTRACT |
|---|
|
|
|---|
Occurrence of transcytosis
in pleural mesothelium was verified by measuring removal of labeled
macromolecules from pleural liquid in experiments without and with
nocodazole. To this end, we injected 0.3 ml of Ringer-albumin with 750 µg of albumin-Texas red or with 600 µg of dextran 70-Texas red in
the right pleural space of anesthetized rabbits, and after 3 h we
measured pleural liquid volume, labeled macromolecule concentration,
and, hence, labeled macromolecule quantity in the liquid of this space.
Labeled albumin left was 318 ± 28 µg in control and 419 ± 17 µg in nocodazole experiments (means ± SE); hence, whereas
ventilation was similar its removal was greater (P < 0.01) in control experiments. Labeled dextran left was 283 ± 10 µg in control and 381 ± 21 µg in nocodazole experiments; hence, whereas ventilation was similar its removal was
greater (P < 0.01) in control experiments. These
findings indicate occurrence of transcytosis from the pleural space.
Liquid removed by transcytosis was 0.05 ml/h. This amount times
unlabeled albumin concentration under physiological conditions (10 mg/ml) times lumen-vesicle partition coefficient for albumin (0.78)
provides fluid-phase albumin transcytosis: ~203
µg · h
1 kg
2/3. Transcytosis might
contribute a relevant part of protein and liquid removal from the
pleural space.
dextran 70; lymphatic drainage from the pleural space; pleural mesothelium; vesicular liquid flow
| |
INTRODUCTION |
|---|
|
|
|---|
WE HAVE, RECENTLY, PROVIDED evidence for transcytosis from the luminal to the interstitial side of specimens of parietal pericardium of rabbit by showing that the unidirectional flux of albumin or dextran 70 from lumen to interstitium is greater than that in the opposite direction and that this difference disappears at 12°C or with a transcytosis inhibitor (8). Our findings agree with earlier morphological evidence for transcytosis of macromolecules from the luminal to the interstitial side of the mesothelium in rat parietal pericardium (18) and mouse parietal peritoneum (13, 14, 16).
In the present research, we tried to provide evidence for transcytosis from the pleural space in vivo. Under physiological conditions, protein removal from the pleural space occurs by lymphatic drainage through the stomata of the parietal mesothelium (2, 5, 20, 21, 23, 25), by solvent drag because of liquid absorption through the visceral mesothelium by Starling forces (1-3), and probably by transcytosis. On the other hand, proteins enter the pleural space by solvent drag because of liquid filtration through the parietal mesothelium by Starling forces (1, 2, 5, 21, 23, 25) and by diffusion because protein concentration in the pleural liquid (22) is smaller than that in the interstitium adjacent to the mesothelium (23). The data obtained on the parietal pericardium in vitro (8) suggest that the removal of albumin from the pleural space by transcytosis might be appreciable even if transcytosis in the pleura were smaller than in the pericardium. One may, therefore, formulate the hypothesis that, in the case of transcytosis, the quantity of labeled albumin left in the pleural liquid a few hours after injection into the pleural space of a bolus with labeled albumin plus nocodazole (a transcytosis inhibitor; Refs. 12, 17) should be greater than that left after a similar bolus injection without nocodazole. Moreover, taking into account that the albumin removed from the pleural space by transcytosis is eventually drained into blood by the lymphatics of the connective tissue of the pleura, one may formulate a second hypothesis: namely, that in case of transcytosis the quantity of labeled albumin occurring in plasma a few hours after injection into the pleural space of a bolus with labeled albumin plus nocodazole should be smaller than that found after a similar bolus injection without nocodazole. To verify these hypotheses, we injected 0.3 ml of albumin-Ringer solution with a small amount of labeled albumin (or dextran 70) into the right pleural space of anesthetized rabbits. Two kinds of experiments were performed: in one the injected bolus contained nocodazole, in the other it did not. After 3 h, we measured the volume of the pleural liquid on the right side and the concentration of labeled albumin (or dextran 70) to determine the quantity of labeled molecules left in the right pleural liquid under the two conditions. Moreover, we measured the concentration of labeled albumin (or dextran 70) in plasma, and, assuming its volume to be 4% of body weight (6, 10, 15), we determined the quantity of labeled macromolecule in plasma under both conditions.
| |
METHODS |
|---|
|
|
|---|
The experiments were performed on 39 rabbits (2.45-2.9 kg
body wt). The animals were anesthetized with pentobarbital sodium (Sigma Chemical, 18 mg/ml); the initial dose was 2 ml/kg intravenously, and small additional injections (0.2 ml/kg) were delivered when required to maintain an adequate level of anesthesia. The trachea was
cannulated, and air flow and tidal volume (obtained by electronic integration of the flow signal by means of a Hewlett-Packard 8815A respiratory integrator) were recorded on a 7418 Hewlett-Packard thermopaper oscillograph throughout the experiment. The left jugular vein was exposed, and 2.5 ml of blood were sampled for background fluorescence measurement (see below). With the rabbit in the
left lateral posture, the sixth right intercostal space was cleared from skin and muscles down to the intercostal muscles. A double thread
loop was prepared in these muscles, and a stainless-steel cannula (1.4 mm OD; 0.9 mm ID) connected to a 1-ml glass syringe containing the
bolus was inserted in the pleural cavity and tightened to the muscles
by one thread loop. The bolus (0.3 ml) was then injected into the
pleural space, and the cannula was removed while the second thread loop
was tightened. During the procedure, a layer of Ringer solution was
maintained over the site of injection to prevent air entrance into the
pleural space during insertion and removal of the cannula. The injected
bolus consisted of a Ringer solution (composition, in mM:
Na+ 139, K+ 5, Ca2+ 2.5, Mg2+ 1.5, Cl
119, HCO
Fluorescence intensity in the liquid collected from the right pleural space at the end of the experiment was measured by a spectrofluorophotometer (Shimadzu RF1501) (excitation 596 nm; emission 615 nm). A calibration curve was made for each experiment by diluting the solution prepared for injection into the pleural space. The background fluorescence of albumin-Ringer solution was measured and subtracted. The calibration was linear over the range of labeled molecule concentration between 0 and 15 µg/ml. A calibration factor was computed for each curve by linear regression through the points. Samples (25 or 50 µl) of the liquid collected from the right pleural space were diluted 120 or 60 times, respectively, with albumin-Ringer solution, so that the reading on the spectrofluorophotometer fell on the linear portion of the calibration curve. Readings were also made of 1) similarly diluted samples of liquid collected from right and left pleural space of two extra rabbits, in which no bolus was injected, to obtain the background fluorescence of pleural liquid; 2) similarly diluted samples of the liquid collected from the left pleural space (where no injection was made), to determine the concentration of labeled molecules entered into this liquid during the experiment; 3) plasma obtained from the blood sampled before injection, to obtain the background fluorescence in plasma; and 4) plasma obtained from the blood sampled at the end of the experiment, to determine the concentration of labeled molecules entered in plasma during the experiment. Readings obtained in pleural liquid and plasma samples at the end of the experiment were corrected for background fluorescence. Checks for the possible occurrence of unbound tracer in the injectate were made by measuring fluorescence intensity in the dialysate (for ~16 h at ~37°C) or ultrafiltrate (by centrifuging at 5,000 g for 30 min through low-binding cellulose ultrafiltration membranes with a 10-kDa nominal molecular weight cutoff, PLTK, Millipore) of diluted solutions of the labeled molecules. The fluorescence found both in the dialysate and in the ultrafiltrate, corresponding to that due to unbound Texas Red, was <0.1% of that in the original solution, both with labeled albumin and with labeled dextran 70. To assess whether macromolecule catabolism occurred in the pleural space, in two experiments with albumin-Texas red and in two experiments with dextran 70-Texas red, diluted samples of the pleural liquid collected at the end of the experiment were ultrafiltered by the above procedure through ultrafiltration membranes with a 30-kDa nominal molecular weight cutoff (PLTK, Millipore). Fluorescence in the filtrate was <0.1% of that in the solution before filtration. Hence, an appreciable catabolism of albumin or dextran 70 does not seem to occur in the pleural space during the experiments.
The quantity of labeled macromolecule present in the pleural liquid of each space at the end of the experiment was obtained by multiplying the corresponding concentration by the overall volume of liquid in the pleural space. This is given by the volume collected plus that remaining adherent to the walls of the space when it is opened. The former was measured, and the latter was computed from the mean value found in previous ad hoc experiments (0.25 ml in 2.23-kg rabbits; Ref. 22). Because the volume of liquid adherent to the walls is related to their surface area, this volume of liquid was computed as 0.25 ml × (body wt2/3/2.232/3). The quantity of labeled macromolecule present in plasma at the end of the experiment was obtained by multiplying the corresponding concentration by the volume of plasma in that rabbit. The volume of plasma was assumed to be 4% of the body weight (Refs. 6, 10, 15). The surface area of the parietal and of the visceral pleura was obtained from previous measurements (22) by normalizing to body weight2/3. Because the surface area of the parietal pleura previously measured was only that facing the lung, the surface area of the costophrenic sinus was added by assuming it to be 1/4 of the parietal pleura facing the lung. The results are reported as means ± SE. Statistical difference between groups was assessed by unpaired t-test.
| |
RESULTS |
|---|
|
|
|---|
Liquid volume.
The volume of liquid in the left pleural space (where no injection was
made) was similar in both kinds of experiments of both series, that
with labeled albumin and that with labeled dextran 70 (Tables
1 and 2).
This volume of liquid was also similar to that previously determined in
ad hoc experiments (4, 22), taking into account the small
difference in body size by normalizing to body weight2/3
(which yields 0.51 ml for the present rabbits). Therefore, the volume
of liquid in the right pleural space at the beginning of the experiment
should be ~0.81 ml, 0.51 ml being the volume under physiological
conditions and 0.3 ml being the injected volume. Because of the
variance in the volume of pleural liquid among rabbits and of the error
involved in its measurement, to get more reliable data it is better to
pool together the values of liquid volume in the right pleural space of
both series of experiments in a given condition, i.e., control or with
nocodazole, so that each group consists of 16 experiments. By so doing,
the volume of the right pleural liquid was smaller (P < 0.01) at the end of control experiments, 0.66 ± 0.04 ml, than
at the end of experiments with nocodazole, 0.81 ± 0.04 ml.
Therefore, transcytosis seems to remove 0.15 ml of liquid from the
pleural space in 3 h, i.e., 0.05 ml/h or 26 µl · h
1 · kg
2/3.
Moreover, the data suggest that in control experiments approximately half of the liquid injected was removed, whereas in the experiments with nocodazole the net removal of liquid was approximately nil.
|
|
Labeled albumin. The quantity of labeled albumin in the right pleural liquid was smaller (P < 0.01) at the end of control experiments, 318 ± 27 µg, than at the end of experiments with nocodazole, 419 ± 17 µg (Table 1). The quantities of labeled albumin left in the right pleural space should be a little greater than those in the right pleural liquid because of the labeled albumin adsorbed to the walls, which is not measured. This, however, does not represent a problem, because the quantity of labeled albumin adsorbed should be similar in both kinds of experiments and because what matters for our aims is the difference in quantity of labeled albumin left in the liquid between the two kinds of experiments. The difference in quantity of labeled albumin left in the right pleural liquid between nocodazole and control experiments, 101 µg, should provide the quantity of labeled albumin removed by transcytosis in 3 h.
The quantity of labeled albumin in plasma was greater (P < 0.01) at the end of control experiments (64.3 ± 6.9 µg) than at the end of experiments with nocodazole (32.5 ± 5.6 µg, Table 1). The finding that the quantity of labeled albumin in plasma is greater in control than in nocodazole experiments fits with the occurrence of transcytosis because, when transcytosis is operating, more labeled albumin is removed from the pleural space, and therefore more labeled albumin reaches the blood.Labeled dextran. The quantity of labeled dextran 70 in the right pleural liquid was smaller (P < 0.01) at the end of control experiments, 283 ± 10 µg, than at the end of experiments with nocodazole, 381 ± 21 µg (Table 2). The same consideration made above on the labeled albumin adsorbed to the walls of the space also applies to the labeled dextran 70 adsorbed to the walls (which might be relatively greater in quantity, because dextran is not normally present in the pleural space). The difference in quantity of labeled dextran left in the right pleural liquid between nocodazole and control experiments, 98 µg, should provide the quantity of labeled dextran removed by transcytosis in 3 h.
The quantity of labeled dextran in plasma was greater (P < 0.01) at the end of control experiments (22.3 ± 1.8 µg) than at the end of experiments with nocodazole (14.4 ± 1.5 µg, Table 2). The finding that the quantity of labeled dextran in plasma is greater in control than in nocodazole experiments fits with the occurrence of transcytosis for the reason mentioned above for labeled albumin.Ventilation. Pulmonary ventilation, as well as that normalized to body weight, was similar in both kinds of experiments of a given series (Tables 1 and 2).
| |
DISCUSSION |
|---|
|
|
|---|
The finding that the quantity of labeled albumin or labeled dextran removed from the right pleural liquid is smaller in the experiments with nocodazole than in control ones suggests the occurrence of transcytosis from lumen to interstitium in the pleural mesothelium in vivo, in line with our in vitro evidence on the parietal pericardium (8). Actually, the quantity of labeled macromolecules removed by transcytosis should be somewhat underestimated because of the following reason. The concentration of labeled macromolecules in the right pleural liquid decreases markedly during the experiment because the liquid entering the pleural space during the experiment is essentially free of labeled macromolecules, whereas these leave the space by lymphatic drainage through the stomata of the parietal pleura (2, 5, 19, 21, 23, 25), by convection owing to the Starling forces through the visceral pleura (1-3), by diffusion (7), and by transcytosis (8). In the experiments with nocodazole, the concentration of labeled macromolecules should decrease more slowly than in control experiments because one mechanism removing macromolecules has been blocked. If the concentration of macromolecules in the experiments with nocodazole is a little higher than in control experiments, the quantity of labeled macromolecules leaving the right pleural space with the other mechanisms should be a little greater in the experiments with nocodazole than in control ones.
Because pulmonary ventilation is similar in the two kinds of experiments of a given series, one can rule out the possibility that our results are affected by a different degree of lymphatic drainage from the pleural space caused by a different degree of ventilation. This control has been done because an increase in lymphatic drainage from large hydrothoraxes has been shown to occur when ventilation is increased (10). Moreover, the finding that the quantity of labeled albumin or labeled dextran 70 in plasma is smaller in the experiments with nocodazole than in control ones fits with the occurrence of transcytosis in pleural mesothelium in vivo. One could argue that nocodazole by disrupting the microtubules could modify the shape of the mesothelial (and endothelial) cells, and this, in turn, might reduce the size of the stomata of the parietal pleura, and, hence, reduce the lymphatic drainage through them. On the other hand, the electron micrographs by Hastings et al. (17) show that the shape of the alveolar and endothelial cells 2 h after instillation of nocodazole in rabbit alveoli was not altered. Moreover, the light micrographs by the same authors show that the shape of rabbit alveoli 2 h after instillation of nocodazole was not changed. The alveolar epithelium lacks a strong support like the connective tissue layers of the pleura: hence, after disruption of the microtubules, it should undergo a change in shape more easily than the mesothelium. Therefore, the finding that the shape of the alveoli is not altered by nocodazole makes it unlikely that the disruption of microtubules alters the shape of the mesothelial cells in such a way as to reduce the size of the stomata of the parietal pleura.
The vesicular transport of albumin in the parietal pericardium of
rabbits in vitro is only fluid phase, although this transcytosis seems
triggered by albumin concentration (8). The situation might be different in vivo, where one cannot rule out the occurrence of
receptors for albumin in the vesicular membrane because one cannot
perform experiments with very low concentrations of unlabeled albumin,
which are required to detect the competition for receptors between
labeled and unlabeled albumin. In case the vesicular transport of
albumin from the pleural space in vivo is only fluid phase, it may be
computed from the vesicular liquid flow (0.05 ml/h, see
RESULTS) times the concentration of albumin in the pleural liquid under physiological conditions (~10 mg/ml; Ref.
22) times the lumen-vesicle partition coefficient for
albumin (~0.78). This coefficient is given by (1
a/r)3 (11), where
a is the hydrodynamic radius of the solute (3.55 nm for
albumin; Ref. 7) and r is the radius of the
vesicle (~45 nm; Refs. 14, 26). This
computation yields a value of 390 µg/h, or 203 µg · h
1 · kg
2/3. On the
other hand, one may attempt to estimate the vesicular transport of
albumin from the pleural space in vivo in a different way that does not
require the assumption of a mere fluid-phase transport. This
computation is based on the vesicular transport of labeled albumin (see
RESULTS) and the ratio between the concentration of
unlabeled albumin in the pleural liquid under physiological conditions
(~10 mg/ml; Ref. 22) and the mean concentration of labeled albumin in the right pleural liquid during the experiment. To
estimate the latter, the time course of the concentration of labeled
albumin in the right pleural liquid (Calb*) during the experiment has
to be approximately drawn. To this end, in a separate group of seven
rabbits we measured 1 h after injection of the control bolus the
same parameters previously measured after 3 h. These data are
reported in Table 3. Because of the
mechanisms involved, the decay of concentration of labeled albumin
should be a curve with upward concavity. The approximate time course of
Calb* during the experiment was obtained by interpolation through the
initial value (see RESULTS), the value after 1 h
(Table 3), and the value after 3 h (Table 1). It is shown in Fig.
1 (
), along with the time course of
the quantity of labeled albumin in the pleural liquid during the
experiment (
). Mean Calb* during the experiment was obtained by
averaging the readings taken on the corresponding line every 12 min.
Its value, 692 µg/ml, is 14.5 times smaller than the concentration of
albumin in the pleural liquid under physiological conditions (10 mg/ml). Therefore, the vesicular transport of albumin from the pleural
space under physiological conditions should be given by the vesicular
transport of labeled albumin during the experiment (101 µg) times
14.5 divided by 3 = ~488 µg/h, or ~254
µg · h
1 · kg
2/3. This
value is 25% greater than that computed from the vesicular liquid
flow. This difference should be even greater because the rate of
vesicular transport of labeled albumin (as it has been measured) is
somewhat underestimated (see above). This difference suggests that the
vesicular transport of labeled albumin from the pleural space in vivo
is not only fluid phase, but the data on which it is based are not
precise enough to afford a conclusion. For the rest of this
DISCUSSION, the vesicular transport of albumin in vivo will
be taken as the mean between the values obtained by the two procedures,
i.e., 439 g/h or 228 µg · h
1 · kg
2/3.
|
|
The surface area of the parietal pleura in our 2.65-kg rabbits should
be ~115 cm2 (see METHODS). Therefore, if
transcytosis occurred only through the parietal pleura, the vesicular
transport of albumin from the pleural space would be ~3.8
µg · h
1 · cm
2 and the
vesicular liquid flow ~0.4
µl · h
1 · cm
2. Though the
morphological features of mesothelial cells seem similar on the
parietal and visceral side, except for a greater density of microvilli
on the visceral side (27), no direct evidence of
transcytosis has been yet provided for the visceral mesothelium. The
surface area of the visceral pleura in our rabbits should be ~132
cm2 (see METHODS). Therefore, the overall
surface area of the parietal and visceral pleura in our rabbits should
be ~247 cm2. If the rate of transcytosis in the visceral
pleura were similar to that in the parietal one, albumin removal from
the pleural space by transcytosis would be ~1.8
µg · h
1 · cm
2 and the
vesicular liquid flow ~0.2
µl · h
1 · cm
2. In vitro
albumin transcytosis through specimens of parietal pericardium of
rabbits, with an albumin concentration in the solution similar to that
occurring under physiological conditions (10 mg/ml), was 5 × 10
4µmol · h
1 · cm
2
or 36 µg · h
1 · cm
2
(8). Therefore, the rate of albumin transcytosis found in the parietal pericardium in vitro is one order of magnitude greater than that found in the pleural space in vivo in the present research. Part of this difference was expected because morphological studies showed a greater concentration of vesicles in the cytoplasm of the
pericardial mesothelium (18, 19) than in that of the
pleural mesothelium (26, 27). Moreover, the rate of
albumin transcytosis measured in the present research should be
somewhat underestimated for the reason indicated above. This
underestimation, however, should not be such as to fill the gap.
The lymphatic drainage from the pleural space of dogs has been
determined by Miniati et al. (20), who made a 0.5-ml
intrapleural injection of Ringer solution with
131I-labeled albumin and a simultaneous intravenous
injection of 125I-labeled albumin. Plasma activity of both
tracers was followed for 24 h: the 131I-labeled
albumin curve provided the output function from the pleural space,
whereas the 125I-albumin curve served as input function for
the interstitial space (including the serosal cavities). They found a
lymphatic drainage from the pleural space of 0.02 ml · h
1 · kg
1. This
lymphatic drainage of albumin was considered to occur mostly through
the stomata of the parietal pleura. Therefore, taking into account that
the concentration of albumin in the pleural liquid of dogs under
physiological conditions is 6.1 mg/ml (22), the lymphatic
drainage of albumin from the pleural space of their 17.5-kg dogs should
be ~122 µg · h
1 · kg
1,
i.e., ~314
µg · h
1 · kg
2/3. On the
other hand, the lymphatic drainage from the pleural space does not
necessarily occur mostly through the stomata, because albumin leaving
the pleural space outside the stomata is also eventually drained into
blood by the lymphatics of the connective tissue of the pleura
(3). Miniati et al. pointed out that the initial upward
concavity of the time course of plasma recovery of labeled albumin
injected into the pleural space (Fig. 9 of their article) is due to a
large liquid volume for albumin distribution interposed between pleura
and plasma. Because they believed that most of albumin removal from the
pleural space occurs through the stomata of the parietal pleura, they
concluded that the lymphatic network was adequate to explain the
delayed appearance of labeled albumin in plasma. The present finding of
albumin transcytosis by the pleural mesothelium suggests that the
lymphatics contribute only part of the initial upward concavity of the
above-mentioned curve, the rest being due to the interstitial liquid of
the pleural connective tissue, where albumin removed by transcytosis
(parietal and, perhaps, visceral pleura) and by convection (visceral
pleura) is distributed before being drained into blood by lymphatics. The possibility that a substantial part of albumin leaves the pleural
space outside the stomata was considered by Broaddus et al.
(9) after they found in sheep that the removal rate of hydrothorax computed from the clearance of labeled erythrocytes (which
may leave the space only through the stomata) was 89% of that computed
from the clearance of labeled albumin. Their hydrothoraxes, however,
were very large (10 ml/kg body wt), and under this condition the
lymphatic drainage from the pleural space may increase more than 10 times (9). Convection too increases (because of the increase in pleural liquid pressure), but to a smaller extent. No
information is available on transcytosis, but its increase should be
smaller than that of the lymphatic drainage. Consequently, the above
difference of 11% between the overall (direct plus indirect) lymphatic
drainage from the pleural space and that through the stomata of the
parietal pleura (direct) should be smaller than that occurring under
physiological conditions.
Unfortunately, no data are available on the lymphatic drainage of albumin from the pleural space of rabbits. It has been stated that the turnover rate of pleural liquid per unit pleural surface area is ~3 times greater in rabbits than in dogs (23). This statement, however, is based on a comparison between an estimate of liquid filtration through the parietal pleura of rabbits (24) and the lymphatic drainage of liquid from the pleural space of dogs, computed from albumin clearance from this space (20). This comparison, in turn, implies the assumption that the lymphatic drainage of liquid from the pleural space represents most of the liquid outflow from the pleural space, and that it occurs through the stomata of the parietal pleura (23). This is not the case because of transcytosis and because of the liquid outflow caused by Starling forces through the visceral pleura and that coupled to the active absorption of NaCl, which are not negligible under physiological conditions (5). Hence the turnover rate of pleural liquid per unit pleural surface area does not seem to be so much greater in rabbits than in dogs. Therefore, our results suggest that under physiological conditions the vesicular transport of liquid and albumin from the pleural space might contribute a substantial part of the overall removal of liquid and albumin from this space.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Prof. D. Cremaschi for stimulating discussion and for critically reading the paper. Moreover, we thank R. Galli for skillful technical assistance.
| |
FOOTNOTES |
|---|
This research was supported by the Ministero dell'Istruzione, dell'Università e della Ricerca of Italy, Rome.
Address for reprint requests and other correspondence: E. Agostoni, Istituto di Fisiologia Umana I, Università di Milano, Via Mangiagalli 32, 20133 Milano, Italy (E-mail: emilio.agostoni{at}unimi.it).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/japplphysiol.00494.2002
Received 5 June 2002; accepted in final form 18 July 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Agostoni, E.
Mechanics of the pleural space.
Physiol Rev
53:
57-128,
1972.
2.
Agostoni, E.
Mechanics of the pleural space.
In: Handbook of Physiology. The Respiratory System. Mechanics of Breathing. Bethesda, MD: Am. Physiol. Soc, 1986, sect. 3, vol. III, p. 531-559.
3.
Agostoni, E,
and
D'Angelo E.
Pleural liquid pressure.
J Appl Physiol
87:
393-403,
1991.
4.
Agostoni, E,
and
Zocchi L.
Solute-coupled liquid absorption from the pleural space.
Respir Physiol
81:
19-28,
1990[ISI][Medline].
5.
Agostoni, E,
and
Zocchi L.
Mechanical coupling and liquid exchanges in the pleural space.
In: Clinics in Chest Medicine: Diseases of the Pleura, edited by Antony VB.. Philadelphia, PA: Saunders, 1998, p. 241-260.
6.
Altman, PL,
and
Dittmer DS.
Respiration and Circulation.
In: Biological Handbooks. Bethesda, MD: FASEB, 1971, p. 381.
7.
Bodega, F,
Zocchi L,
and
Agostoni E.
Macromolecule transfer through mesothelium and connective tissue.
J Appl Physiol
89:
2165-2173,
2000
8.
Bodega, F,
Zocchi L,
and
Agostoni E.
Albumin transcytosis in mesothelium.
Am J Physiol Lung Cell Mol Physiol
282:
L3-L11,
2002
9.
Broaddus, VC,
Wiener-Kronish JP,
Berthiaume Y,
and
Staub NC.
Removal of pleural liquid and protein by lymphatics in awake sheep.
J Appl Physiol
64:
384-390,
1988
10.
Courtice, FC,
and
Simmonds WJ.
Absorption of fluid from the pleural cavities of rabbits and cats.
J Physiol
109:
117-130,
1949
11.
Curry, FE.
Mechanics and thermodynamics of transcapillary exchange.
In: Handbook of Physiology. The Cardiovascular System. Microcirculation. Bethesda, MD: Am. Physiol. Soc, 1984, sect. 2, vol. IV, p. 309-374.
12.
Deffebach, ME,
Bryan CJ,
and
Hoy CM.
Protein movement across cultured guinea pig trachea: specificity and effect of transcytosis inhibitors.
Am J Physiol Lung Cell Mol Physiol
271:
L744-L752,
1996
13.
Fedorko, ME,
and
Hirsch JG.
Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. I. Morphologic aspects.
Exp Cell Res
69:
113-127,
1971[ISI][Medline].
14.
Fedorko, ME,
Hirsch JG,
and
Fried B.
Studies on transport of macromolecules and small particles across mesothelial cells of the mouse omentum. II. Kinetic features and metabolic requirements.
Exp Cell Res
69:
313-323,
1971[ISI][Medline].
15.
Gillen, CM,
Takamata A,
Mack GW,
and
Nadel ER.
Measurement of plasma volume in rats with use of fluorescent-labeled albumin molecules.
J Appl Physiol
76:
485-489,
1994
16.
Gotloib, L,
and
Shostak A.
Endocytosis and transcytosis of albumin gold through mice peritoneal mesothelium.
Kidney Int
47:
1274-1284,
1995[ISI][Medline].
17.
Hastings, RH,
Wright JR,
Albertine KH,
Ciriales R,
and
Matthay MA.
Effect of endocytosis inhibitors on alveolar clearance of albumin, immunoglobulin G and SP-A in rabbits.
Am J Physiol Lung Cell Mol Physiol
266:
L544-L552,
1994
18.
Kluge, T.
Pericardial absorption of thorium dioxide in rats. I. An electron microscopical study.
Acta Pathol Microbiol Scand
72:
64-86,
1968[ISI][Medline].
19.
Kluge, T,
and
Hovig T.
The ultrastructure of human and rat pericardium. I. Parietal and visceral mesothelium.
Acta Pathol Microbiol Scand
71:
529-546,
1967[ISI][Medline].
20.
Miniati, M,
Parker JC,
Pistolesi M,
Cartledge JT,
Martin DJ,
Giuntini C,
and
Taylor AE.
Reabsorption kinetics of albumin from pleural space in dogs.
Am J Physiol Heart Circ Physiol
255:
H375-H385,
1988
21.
Miserocchi, G.
Pleural liquid pressure.
In: The Pleura in Health and Disease, edited by Chrétien Y,
Bignon Y,
and Hirsch A.. New York: Dekker, 1985, p. 151-168.
22.
Miserocchi, G,
and
Agostoni E.
Contents of the pleural space.
J Appl Physiol
30:
208-213,
1971
23.
Miserocchi, G,
and
Negrini D.
Pleural space: pressure and fluid dynamics.
In: The Lung: Scientific Foundations, edited by Crystal RG,
and West JB.. Philadelphia, PA: Lippincott-Raven, 1997, p. 1217-1225.
24.
Negrini, D,
Venturoli D,
Townsley MI,
and
Reed RK.
Permeability of parietal pleura to liquid and proteins.
J Appl Physiol
76:
627-633,
1994
25.
Staub, NC,
Wiener-Kronish JP,
and
Albertine KH.
Transport through the pleura.
In: The Pleura in Health and Disease, edited by Chrétien Y,
Bignon Y,
and Hirsch A.. New York: Dekker, 1985, p. 169-193.
26.
Wang, N.
Mesothelial cells in situ.
In: The Pleura in Health and Disease, edited by Chrétien Y,
Bignon Y,
and Hirsch A.. New York: Dekker, 1985, p. 23-42.
27.
Wang, N.
Anatomy of the pleura.
In: Clinics in Chest Medicine: Diseases of the Pleura, edited by Antony VB.. Philadelphia, PA: Saunders, 1998, p. 229-240.
28.
Zocchi, L,
Cremaschi D,
and
Agostoni E.
Liquid volume, Na+ and mannitol concentration in a hypertonic mannitol-Ringer hydrothorax.
Respir Physiol
89:
341-351,
1992[ISI][Medline].
This article has been cited by other articles:
![]() |
S. J. LAI-FOOK Pleural Mechanics and Fluid Exchange Physiol Rev, April 1, 2004; 84(2): 385 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zocchi Physiology and pathophysiology of pleural fluid turnover Eur. Respir. J., December 1, 2002; 20(6): 1545 - 1558. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |